Latest acute leukemia Stories
SEATTLE, April 21, 2015 /PRNewswire/ -- Seattle Children's announced today that 20 of 22 patients treated thus far in a clinical trial using genetically reprogrammed T cells to treat relapsed
EWING, N.J., April 6, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
WHITE PLAINS, N.Y., March 30, 2015 /PRNewswire-USNewswire/ -- A promising University of Michigan research project focused on developing new treatments for patients with a rare and lethal subtype
BEVERLY HILLS, Calif., March 24, 2015 /PRNewswire/ -- Rich Pharmaceuticals, Inc.
Highly sensitive genomic analysis of acute lymphoblastic leukemia cells reveals for the first time how the malignant cells evolve to cause relapse MEMPHIS, Tenn., March 19, 2015 /PRNewswire-USNewswire/
EWING, N.J., March 17, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
BEVERLY HILLS, Calif., March 12, 2015 /PRNewswire/ -- Rich Pharmaceuticals, Inc.
SAN DIEGO and TORONTO, March 3, 2015 /PRNewswire/ - Aptose Biosciences Inc.
- Of or relating to good digestion.